Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer.
published in: Targeted oncology
date of publication: 2017-10-01
Cites articles 60
Date
Title
Article - wd:Q38720801
Article - wd:Q38720801